Post-transplant drug may also help patients with common genetic kidney disease

The immunosuppressive drug sirolimus considerably improves the kidney health of patients with autosomal dominant polycystic kidney disease (ADPKD), according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that this agent may be a promising treatment option for patients with ADPKD -the most common genetic kidney disease and a major cause of kidney failure.

Read the whole article on Physorg

More from Physorg